Susman E J, Dorn L D, Fletcher J C
Laboratory of Developmental Psychology, National Institute of Mental Health, Bethesda, Maryland.
J Pediatr. 1992 Oct;121(4):547-52. doi: 10.1016/s0022-3476(05)81142-4.
We examined the capacity of children, adolescents, and young adults to assent and consent to participation in biomedical research, and what physician-investigators believe is important for patients in these age groups to know about such participation. The sample included 44 male and female subjects, ranging in age from 7 to 20 years, who were hospitalized to treat either pediatric cancer or obesity. The participants completed a structured interview that assessed knowledge of research participation using the elements outlined in the federal guidelines for informed consent. The study subjects were most knowledgeable about those elements of consent that assessed concrete information (e.g., freedom to ask questions, time elements involved, and the benefits of participation). They were less knowledgeable about those elements of informed consent that assessed abstract information (e.g., scientific vs therapeutic purpose of the study, and alternative treatments). Chronologic age was not related to knowledge of the elements of informed consent. The strategies that the study subjects used to reason about participation in research appeared to parallel their reasoning about other physical phenomena.
我们研究了儿童、青少年和青年同意参与生物医学研究的能力,以及医师研究人员认为这些年龄组的患者了解此类参与的哪些内容很重要。样本包括44名年龄在7至20岁之间的男性和女性受试者,他们因治疗儿童癌症或肥胖症而住院。参与者完成了一项结构化访谈,该访谈使用联邦知情同意指南中概述的要素评估对研究参与的了解。研究对象对评估具体信息(例如提问的自由、所涉及的时间要素以及参与的益处)的同意要素了解最多。他们对评估抽象信息(例如研究的科学目的与治疗目的以及替代治疗)的知情同意要素了解较少。实际年龄与对知情同意要素的了解无关。研究对象用于思考参与研究的策略似乎与他们对其他物理现象的推理相似。